Iconovo (ICO.ST) Stock Price

Iconovo Price

OMX·CLOSED
0.98
​
Market closed

Over the last 10 years Iconovo grew revenue by 22.1% annually, reaching 1.11 M SEK. For Iconovo, the net margin of -3,924.3% is down versus -169.8% a few years ago.

Iconovo stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Iconovo business model & stock analysis

Iconovo AB, headquartered in Lund, Sweden, operates in the Health Care sector, specializing in the development, manufacturing, and supply of inhalation products. The company employs 32 full-time staff and was listed on the stock market on 6 April 2018. Iconovo's product portfolio includes device platforms such as ICOres, ICOone, ICOcap, and ICOpre, alongside formulation, analytical testing, and documentation services. It also provides programs for developing generic inhalation products and conducting phase I-II clinical trials.

Frequently asked questions about Iconovo

5 analysts currently rate the Iconovo stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Iconovo to generate revenue of 29.00 M SEK and earnings per share of -0.64 SEK.

Converted at the current exchange rate, the Iconovo share trades at 0.09 EUR (0.98 SEK).

The Iconovo share (ICO.ST) is listed on 2 stock exchanges, including: Stockholm (ICO.ST).

The expected revenue of Iconovo is 29.00 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Iconovo is -34.41 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Iconovo is currently -1.54. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Iconovo stock.

The price-to-sales ratio (P/S) of Iconovo is currently 1.82. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Iconovo stock.

The Eulerpool Quality Score for Iconovo is 2/10.

The ISIN of Iconovo is SE0010868943. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Iconovo is ICO.ST. The ticker symbol is used to trade Iconovo shares on the stock exchange.

Fair ValueTerminal
0.83 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
34,531.25 SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website iconovo.se
Country
Sweden
Currency
SEK
Initial public offering
Apr 6, 2018
ISIN
SE0010868943
Cusip
W4R429132
Market capitalization
73.15 M SEKMicro Cap
52-Week Range
PEG
0.20
P/E ratio
P/Ee 2026
-1.54
P/Ee 2027
-1.86
P/Ee 2028
-1.86
P/Se
1.82
EV/EBIT
—
P/B Ratio
0.62
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-35.29 %
Last updated Oct 18, 2026, 3:12 PM

Iconovo Peer Group

Iconovo Ticker

STOCKHOLM · ICO.STSTOCKHOLM · ICO.ST

Iconovo FIGI

ICO:SF · BBG00K8DZDH3ICOS:PO · BBG00KK34DQ5ICOS:L3 · BBG00KK34DX7ICOS:B3 · BBG00KK34FQ0ICOSEK:XS · BBG00KK34KR8ICOSEK:XH · BBG00KK34KV3ICOSEK:XF · BBG00KK34KX1ICOSEK:XE · BBG00KK34KZ9ICOSEK:XJ · BBG00KK34L05ICOSEK:XL · BBG00KK34L14ICOSEK:XG · BBG00KK34L23ICOSEK:XO · BBG00KK34L32

All fundamentals and in-depth analysis of Iconovo

Our stock analysis for Iconovo stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Iconovo. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.